Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Cannabis
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Isracann Biosciences Inc
Bullboard Posts
User Avatar Image
(13)
•••
Post by LatAmBullon Dec 03, 2019 10:12am
222 Views
Post# 30416928

IMCC further along than IPOT; $10 million of 2019 revenue.

IMCC further along than IPOT; $10 million of 2019 revenue.If you are interested in the Israeli cannabis space, I highly recommend you check out IMCC. 

Valuation is very cheap relative to IPOT given 2019 run-rate revenue of ~$10 million in Israeli market + EU market opportunity through German distributor ownership. Company has built leading IP, strong brands, and has a highly credible management team. Company has built leading IP ovder last 10 years, has strong products/brand, and has a highly credible management team.

IMCC/IPOT trade at a similar valuation but IMCC is significantly further along. Not to say that IPOT isn't a good bet either, but if you are interested in this Israeli/EU opportunity, recommend you check out this opportunity as well. 


Link to Q3 earnings release: 

IMC HOLDINGS INCREASES CONSOLIDATED REVENUES BY 70% IN Q3'19
https://www.stockwatch.com/News/Item?bid=Z-C%3aIMCC-2840709&symbol=IMCC&region=C 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities